Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Block | 3 | 2018 | 7 | 1.270 |
Why?
|
| Laparoscopy | 3 | 2018 | 146 | 1.130 |
Why?
|
| Anesthetics, Local | 2 | 2017 | 12 | 1.120 |
Why?
|
| General Surgery | 2 | 2017 | 55 | 1.020 |
Why?
|
| Abdominal Wall | 2 | 2018 | 9 | 0.730 |
Why?
|
| Neoadjuvant Therapy | 3 | 2018 | 73 | 0.640 |
Why?
|
| Receptor, ErbB-2 | 2 | 2018 | 33 | 0.620 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 464 | 0.590 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 2 | 0.560 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 11 | 0.560 |
Why?
|
| Rectus Abdominis | 1 | 2017 | 1 | 0.550 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 62 | 0.550 |
Why?
|
| Workload | 1 | 2017 | 38 | 0.550 |
Why?
|
| Fatigue | 1 | 2017 | 64 | 0.540 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 39 | 0.530 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 20 | 0.530 |
Why?
|
| Attitude | 1 | 2016 | 44 | 0.510 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 60 | 0.500 |
Why?
|
| Students, Medical | 1 | 2016 | 96 | 0.480 |
Why?
|
| Gallstones | 1 | 2014 | 9 | 0.460 |
Why?
|
| Thoracic Injuries | 2 | 2025 | 10 | 0.450 |
Why?
|
| Internship and Residency | 1 | 2017 | 239 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 534 | 0.430 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2025 | 52 | 0.430 |
Why?
|
| Plasmacytoma | 1 | 2013 | 5 | 0.410 |
Why?
|
| Pancreatic Fistula | 2 | 2019 | 14 | 0.320 |
Why?
|
| Humans | 18 | 2025 | 28121 | 0.310 |
Why?
|
| Retrospective Studies | 7 | 2025 | 2557 | 0.300 |
Why?
|
| Female | 12 | 2025 | 15156 | 0.290 |
Why?
|
| Male | 10 | 2025 | 13487 | 0.290 |
Why?
|
| Child | 6 | 2025 | 2242 | 0.290 |
Why?
|
| Lupus Erythematosus, Cutaneous | 2 | 2016 | 15 | 0.250 |
Why?
|
| Antimalarials | 2 | 2016 | 25 | 0.250 |
Why?
|
| Vascular System Injuries | 1 | 2025 | 19 | 0.240 |
Why?
|
| Body Size | 1 | 2025 | 37 | 0.240 |
Why?
|
| Aorta, Thoracic | 1 | 2025 | 55 | 0.230 |
Why?
|
| Endovascular Procedures | 1 | 2025 | 70 | 0.230 |
Why?
|
| Adult | 8 | 2019 | 7757 | 0.210 |
Why?
|
| Multiple Trauma | 1 | 2023 | 23 | 0.200 |
Why?
|
| Biomarkers, Tumor | 2 | 2017 | 406 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 30 | 0.200 |
Why?
|
| Middle Aged | 7 | 2019 | 7164 | 0.190 |
Why?
|
| Binge-Eating Disorder | 1 | 2021 | 6 | 0.190 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 11 | 0.190 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 678 | 0.190 |
Why?
|
| Prognosis | 3 | 2018 | 803 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 54 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 477 | 0.180 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 238 | 0.170 |
Why?
|
| Logistic Models | 2 | 2018 | 407 | 0.170 |
Why?
|
| Pancreatectomy | 1 | 2019 | 58 | 0.160 |
Why?
|
| Pancreas | 1 | 2019 | 61 | 0.160 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 70 | 0.160 |
Why?
|
| Anastomotic Leak | 1 | 2018 | 9 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2018 | 611 | 0.150 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2018 | 42 | 0.150 |
Why?
|
| Gastroschisis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 15 | 0.150 |
Why?
|
| Area Under Curve | 1 | 2018 | 95 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2018 | 35 | 0.150 |
Why?
|
| Instillation, Drug | 1 | 2017 | 7 | 0.150 |
Why?
|
| Ovarian Cysts | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cholecystectomy | 1 | 2017 | 15 | 0.140 |
Why?
|
| Appendectomy | 1 | 2017 | 14 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2017 | 26 | 0.140 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2017 | 5 | 0.140 |
Why?
|
| Calcineurin Inhibitors | 1 | 2016 | 5 | 0.140 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 462 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2017 | 41 | 0.130 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 61 | 0.130 |
Why?
|
| Retinoids | 1 | 2016 | 38 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 135 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 108 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2017 | 128 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 75 | 0.130 |
Why?
|
| Aged | 5 | 2018 | 5416 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 330 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 148 | 0.120 |
Why?
|
| Algorithms | 1 | 2018 | 433 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2017 | 886 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2017 | 1249 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 372 | 0.100 |
Why?
|
| Adolescent | 4 | 2025 | 3123 | 0.100 |
Why?
|
| Jaundice, Obstructive | 1 | 2013 | 3 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2025 | 2380 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 24 | 0.100 |
Why?
|
| United States | 1 | 2017 | 2149 | 0.090 |
Why?
|
| Smoking | 1 | 2014 | 473 | 0.080 |
Why?
|
| Risk Factors | 3 | 2019 | 2084 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 2021 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2018 | 114 | 0.070 |
Why?
|
| Length of Stay | 1 | 2025 | 232 | 0.060 |
Why?
|
| Bronchi | 1 | 2023 | 38 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2021 | 36 | 0.050 |
Why?
|
| Stomach | 1 | 2021 | 43 | 0.050 |
Why?
|
| Drainage | 1 | 2019 | 45 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 63 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 105 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2731 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 37 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 31 | 0.040 |
Why?
|
| Mastectomy | 1 | 2018 | 21 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 104 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2018 | 110 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 125 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 289 | 0.030 |
Why?
|
| Dapsone | 1 | 2016 | 1 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 43 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2016 | 17 | 0.030 |
Why?
|
| Thalidomide | 1 | 2016 | 13 | 0.030 |
Why?
|
| Methotrexate | 1 | 2016 | 34 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 465 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 194 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 75 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 300 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 432 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 167 | 0.030 |
Why?
|
| Biological Products | 1 | 2016 | 65 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 722 | 0.030 |
Why?
|
| Pain | 1 | 2018 | 258 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1014 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 242 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 613 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 755 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 1181 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 454 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 968 | 0.020 |
Why?
|